Albemarle's EBITDA to Benefit From Higher Lithium Prices, RBC Says
Idag, 17:50
11:50 AM EDT, 05/11/2026 (MT Newswires) -- Albemarle's (ALB) earnings before interest, taxes, depreciation, and amortization, or EBITDA, will likely benefit from stronger
Lithium prices in the range of low to mid-$20s per kilogram, RBC Capital Markets analysts said in a note emailed Monday.
The company posted "strong"Q1 financial results that beat estimates and raised its annual specialties guidance, analysts said.
RBC said that ALB continues to ramp its CGP3 projects and make progress on several brownfield opportunities, which should drive mid-single-digit percentage growth in 2027 and beyond.
Analysts said the company could provide further details on brownfield investments and capital return in its Q3 financial results.
RBC said it remains optimistic for significant EBITDA growth for fiscal 2026 and raised its EBITDA estimate for the company to $650 million from $600 million for Q2.
Analysts retained an outperform rating on the stock and increased its price target to $253 from $245.
Price: 215.62, Change: +12.10, Percent Change: +5.95
Albemarle's EBITDA to Benefit From Higher Lithium Prices, RBC Says
Idag, 17:50
11:50 AM EDT, 05/11/2026 (MT Newswires) -- Albemarle's (ALB) earnings before interest, taxes, depreciation, and amortization, or EBITDA, will likely benefit from stronger
Lithium prices in the range of low to mid-$20s per kilogram, RBC Capital Markets analysts said in a note emailed Monday.
The company posted "strong"Q1 financial results that beat estimates and raised its annual specialties guidance, analysts said.
RBC said that ALB continues to ramp its CGP3 projects and make progress on several brownfield opportunities, which should drive mid-single-digit percentage growth in 2027 and beyond.
Analysts said the company could provide further details on brownfield investments and capital return in its Q3 financial results.
RBC said it remains optimistic for significant EBITDA growth for fiscal 2026 and raised its EBITDA estimate for the company to $650 million from $600 million for Q2.
Analysts retained an outperform rating on the stock and increased its price target to $253 from $245.
Price: 215.62, Change: +12.10, Percent Change: +5.95
Analys
Analys
Marknadsöversikt
1 DAG %
Senast
1 mån
